Quick Summary
- On April 18, 2026, President Trump signed an executive order fast-tracking ibogaine review at the fda, flanked by rfk jr., joe rogan, and the CEO of americans for ibogaine.
- FDA Commissioner Marty Makary confirmed ibogaine could move to approval within one to two months via National Priority Vouchers once trial data arrives.
- Ameen Alai is sitting in FMC Fort Worth serving 48 months for advocating the exact treatment the federal government now calls a national priority.
- The opioid math is brutal. 80,000 dead in 2024. Roughly 5.9 million actively addicted. One dose of ibogaine reports an 80% freedom rate. Two doses, over 90%.
- Every month Ameen stays locked up is a month the federal government criminalizes its own new priority. Clemency is the only honest move.
The Executive Order That Rewrote the Ground Ameen Is Buried Under
On April 18, 2026, Donald Trump sat in the Oval Office and signed an executive order fast-tracking FDA review of ibogaine for the treatment of addiction, PTSD, and traumatic brain injury. Standing behind him were health and Human Services Secretary Robert F. Kennedy Jr., FDA Commissioner Marty Makary, NIH Director Jay Bhattacharya, joe rogan, Marcus Luttrell, and W. Bryan Hubbard, the CEO of Americans for Ibogaine.
Rogan told the room he had texted the president about ibogaine. Trump’s reply, according to Rogan: “Sounds great. Do you want FDA approval? Let’s do it.” Luttrell, the Navy SEAL whose story became Lone Survivor, turned to the president and said, “You’re going to save a lot of lives through it.”
Two days later, FDA Commissioner Makary went on CNN and said ibogaine could receive approval within one to two months once late-stage trial data is submitted, through a new National Priority Voucher pathway. He confirmed that investigational new drug clearance had been issued for ibogaine the prior week, allowing it to be shipped across state lines for clinical research.
The same week all of that happened, a father named Ameen Alai was waking up in a federal prison cell in Fort Worth, Texas. Inmate number 24155-509. Serving 48 months for distribution of a Schedule I substance. The substance was ibogaine.
Who Ameen Alai Actually Is
In bodybuilding and biohacking circles Ameen Alai is known as guru ameen or the Mad Scientist. Coach, father, researcher, and one of the earliest American voices arguing that ibogaine could interrupt opioid addiction and break trauma loops the pharmaceutical industry has been failing to treat for thirty years.
Long before Rick Perry was on Rogan making the case for federal reform, long before Texas put $50 million into ibogaine research, long before connor mcgregor posted about his treatment in Tijuana saving his life, long before Kennedy tweeted that he would decriminalize psychedelic medicines if elected, Ameen was talking about this compound to anyone who would listen. He was doing it in a country that classifies ibogaine alongside heroin. He understood what that meant. He did it anyway because he believed the cost of silence was higher than the cost of prosecution.
In March 2021, a bodybuilder named Andy Haman died after an ibogaine session in Colorado. The tragedy is real and nothing in this article pretends otherwise. Haman had an enlarged heart. He had restricted coronary arteries. Five days before the session he had undergone surgery for an infection and his wife reported he was septic, meaning his body was already in life-threatening response to systemic infection. The coroner listed all of that in the autopsy alongside ibogaine toxicity.
Federal prosecutors initially charged Ameen with “distribution resulting in death,” a charge that carries a 20-year mandatory minimum. That charge was dropped. Why? Because prosecutors could not establish direct causation. They could not prove in court that ibogaine alone killed Andy Haman. So they pivoted to a plain distribution charge, secured a plea, and gave Ameen four years in a federal prison.
Four years. For advocating a treatment the same federal government, one administration later, would put on a National Priority Voucher track.
The Opioid Math Nobody in Power Can Look Away From Anymore
In 2024, more than 80,000 Americans died from drug overdoses. Roughly 5.9 million Americans are currently dependent on opioids. Those are not biohacker talking points. Those are CDC numbers that Rogan cited on Instagram the day Trump signed the order, to his nearly twenty million followers.
A 2024 open-label Stanford trial of thirty US special operations veterans with traumatic brain injury, treated with magnesium-ibogaine, reported an 88% average reduction in PTSD symptoms, 87% in depression, and 81% in anxiety, measured one month post-treatment. Ibogaine clinics operating legally in Mexico report single-dose freedom-from-opioid-addiction rates around 80%, and 90%+ with a second dose.
Compare that to what the American medical system currently offers an opioid addict. Methadone, which substitutes one dependency for another and produces a new withdrawal syndrome on its own. Suboxone, same profile. Twenty-eight day rehabs with five-figure price tags and relapse rates that nobody in the industry prints on their brochures because they would collapse the business model.
One night of ibogaine, properly administered with cardiac monitoring and magnesium co-administration, reports outcomes that thirty years of pharmaceutical addiction medicine cannot touch. That is the reality Rick Perry brought to the Oval Office. That is the reality Luttrell looked Trump in the eye and confirmed. That is the reality Ameen Alai has been saying out loud in fitness podcasts and gym back rooms since before any of those men were willing to.
What Changed Between His Sentencing and Right Now
In November 2022, Colorado voters decriminalized natural psychedelics. A state panel is currently writing the regulatory framework for supervised ibogaine treatment in Colorado, expected to launch the first legal US ibogaine therapy program.
In 2024, Texas committed $50 million to ibogaine research under Rick Perry’s advocacy. Kentucky and Mississippi are weighing similar measures.
In 2025, Connor McGregor, one of the most recognizable athletes alive, publicly credited ibogaine with saving his life. “I was saved,” he wrote. “My brain. My heart. My soul. Healed.” Brett Favre has spoken about it. Keith Jardine has spoken about it. Kennedy, now running American health policy, called for legalization of all psychedelic medicines during his presidential campaign and specifically named ibogaine.
On April 18, 2026, the president of the United States signed an executive order to accelerate FDA approval of ibogaine. Four days later the fda commissioner said approval could come within sixty days.
None of that changes Ameen’s sentence by a single day. He is scheduled for release somewhere around 2028 or 2029. He will watch from inside a federal medical center as the compound he was imprisoned for advocating becomes legal medicine. He will watch clinics charge fifteen to twenty thousand dollars a session for exactly the treatment he was trying to make accessible.
The Question Every Honest Person Has to Answer Now
If ibogaine has no accepted medical use and a high potential for abuse, as Schedule I status claims, then Trump, Kennedy, Makary, Bhattacharya, and the entire FDA leadership just committed federal resources to a substance with no medical value. That position is incoherent.
If ibogaine does have medical value, which is now the official position of the executive branch, the FDA, and HHS, then what exactly is Ameen Alai still in prison for?
The Department of Justice cannot have it both ways. Either the compound is dangerous garbage with no therapeutic use, in which case Trump’s executive order is malpractice at a federal scale. Or the compound is a legitimate treatment for conditions killing tens of thousands of Americans a year, in which case every day Ameen sits in Fort Worth is a day the federal government is punishing a man for being early to a consensus it has now officially adopted.
Four years for being right before the establishment was ready to admit he was right. That is the crime Ameen Alai is actually serving time for. It is not justice. It is not proportionate. It is not even internally consistent with current federal policy.
The Case for Clemency Is Not Complicated
A presidential pardon or commutation from Trump would accomplish several things at once. It would correct a scheduling-driven injustice that has already been superseded by his own executive order. It would send a signal to the psychedelic research community that the administration is not merely rebranding prohibition as reform. It would tell the millions of Americans currently addicted to opioids, and the veterans currently waiting for ibogaine clinics to open legally, that the federal government is not going to keep prosecuting the early advocates of the treatments it is now fast-tracking.
It would also put the president on the right side of a story that is about to become impossible to ignore. Andrew and Tristan Tate donated $10,000 to Ameen’s legal defense. McGregor has been vocal about ibogaine. Rogan has the biggest podcast in the world and the president’s ear. The #FreeAmeen petition is gathering signatures. The next logical chapter writes itself.
A father gets to come home to his son. A man whose worst crime was believing in a medicine ahead of the FDA gets his life back. The federal government stops the absurdity of simultaneously criminalizing and fast-tracking the exact same compound. And the cultural permission structure opens for the next hundred thousand addicts and veterans to access a treatment that credible data suggests could save their lives.
What You Can Actually Do
Sign the petition at FreeAmeen.org. Sign the Change.org clemency petition. Share Ameen’s story. Tag Rogan, tag Kennedy, tag Hubbard at Americans for Ibogaine, tag the White House. The executive order that vindicates Ameen’s position was signed because Rogan texted Trump. The pardon that frees Ameen will be signed because the same pressure gets applied in the same direction.
Bryan Hubbard stood in the Oval Office on April 18th. He represents Americans for Ibogaine. the natural next move for his organization, and for everyone who cheered that signing, is to demand that the administration free the American who was punished for advocating ibogaine before it was safe for the establishment to do the same.
Ibogaine is about to become legal medicine. The man who lost four years of his life trying to tell America it was medicine should not be the last person still paying the price for that delay.
The Bigger Pattern
There is a pattern in American medical history that repeats every time an emerging treatment threatens an entrenched industry. The early advocates get punished. The establishment resists. The evidence eventually wins. And then the people who were right from the beginning are erased from the official story while the people who resisted longest reposition themselves as thought leaders.
It happened with testosterone replacement therapy. It happened with growth hormone. It happened with psilocybin. It happened with MDMA. It is happening right now with peptides, as the FDA circles compounds that Mexican clinics and European longevity centers have been using responsibly for a decade.
Ameen Alai is the ibogaine case in that pattern. He is not perfect. He is not a saint. He is a man who believed a medicine could save lives, who advocated for it publicly, who was present at a tragedy whose causation has never been cleanly established, and who was prosecuted while the actual seller and administrator continued operating his business.
The federal government has now declared his position correct. The only remaining question is whether the federal government has the moral consistency to release him.
Free Ameen Alai. It is the right call. It is the obvious call. And given what Trump just signed on April 18th, it is the only call that makes any sense at all.
References
- Associated Press. “Trump signs order to hasten review of psychedelics.” PBS NewsHour, April 18, 2026.
- ABC News. “Trump signs executive order accelerating research into psychedelic drug therapies.” April 18, 2026.
- CNN Health. “Ibogaine is drawing new interest from the Trump administration.” April 22, 2026.
- Cherian KN, Keynan JN, Anker L, et al. “Magnesium-ibogaine therapy in veterans with traumatic brain injuries.” Nature Medicine, 2024.
- Mash DC, Duque L, Page B, Allen-Ferdinand K. “Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence.” Frontiers in Pharmacology, 2018.
- CBS Colorado. “Colorado man’s federal drug sentence comes months before expected state approval of ibogaine use.” February 2, 2026.
- Artvoice. “The Crucifixion of Ameen Alai.” February 17, 2026.
- Fortune. “Trump speeds review of psychedelics after joe rogan texted him about ibogaine.” April 18, 2026.
- FreeAmeen.org clemency campaign.
- CDC National Center for Health Statistics. Drug Overdose Deaths in the United States, 1999-2024.
Frequently Asked Questions
What exactly did Trump’s executive order on April 18, 2026 do for ibogaine?
The executive order directs the FDA to fast-track clinical trial support and approval review for ibogaine and other psychedelics, commits $50 million in federal funding to state-level psychedelic research, authorizes National Priority Voucher status that compresses FDA review to one to two months, and opens the door to inclusion under the right to try Act. FDA Commissioner Marty Makary confirmed that investigational new drug clearance for ibogaine was issued the week of the signing.
Why is Ameen Alai in federal prison?
Ameen Alai was sentenced in September 2025 to 48 months in federal prison for distribution of ibogaine, a Schedule I controlled substance, following the death of bodybuilder Andy Haman after a 2021 ibogaine session in Colorado. Federal prosecutors originally charged him with distribution resulting in death, which carries a 20-year mandatory minimum, but dropped that charge when they could not establish direct causation.
Has anyone ever been convicted of an ibogaine-related federal crime before Ameen?
No. Ameen Alai is the first person in US history to be imprisoned for an ibogaine-related federal charge.
Is ibogaine actually effective for addiction and PTSD?
A 2024 stanford-led open-label trial of thirty US special operations veterans reported 88% reduction in PTSD symptoms, 87% reduction in depression, and 81% reduction in anxiety one month after magnesium-ibogaine treatment. Legal clinics in Mexico report roughly 80% single-dose and over 90% two-dose opioid freedom rates.
How can someone support Ameen Alai’s clemency?
Sign the official petition at FreeAmeen.org. Contact the White House pardon office. Amplify the case on social media, tagging joe rogan, rfk jr., Americans for Ibogaine CEO Bryan Hubbard, and the president directly.
Frequently Asked Questions
What is ibogaine and why is it illegal?
Ibogaine is a naturally occurring alkaloid from the iboga plant with potential therapeutic applications for addiction treatment. It's been illegal in the US since 2002 due to safety concerns and lack of FDA approval, though it remains legal in some countries. Recent executive actions aim to expedite its clinical review process.
How long does ibogaine FDA approval typically take?
Under Trump's April 2026 executive order using National Priority Vouchers, ibogaine could receive FDA approval within one to two months of trial data submission. This fast-track process significantly accelerates the standard timeline, which typically requires years of clinical evaluation and regulatory review.
Why is Ameen Alai still in prison if ibogaine is being legalized?
Ameen Alai was convicted under previous federal laws criminalizing ibogaine advocacy and distribution. Executive orders and regulatory changes don't retroactively commute sentences for past convictions. His case represents individuals imprisoned before legal status changed, highlighting the distinction between future legalization and past prosecutions.
About tony huge
Tony Huge is a self-experimenter, biohacker, and founder of enhanced labs. He has spent over a decade researching and personally testing peptides, SARMs, anabolic compounds, nootropics, and longevity protocols. Tony’s mission is to push the boundaries of human potential through science, transparency, and direct experience. Follow his research at tonyhuge.is.